Home › Eczema › Florida › Miami
Eczema clinical trials in Miami, FL
4 studies for Eczema are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
RecruitingPhase 1Healthy volunteers welcome
- Clinical Site 110, Miami
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Miami
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Quality Care Clinical Research, Miami
- FXM Clinical Research Miami, LLC, Miami
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- Floridian Research Institute Llc, Miami
About Eczema
Eczema is a general term for different types of rashes. Atopic dermatitis, the most common type, is an allergic skin reaction. Read about treatments.
More about Eczema on MedlinePlus
Eczema trials in other cities
- San Antonio, TX7 studies
- Birmingham, AL6 studies
- Indianapolis, IN5 studies
- Los Angeles, CA5 studies
- New York City, NY5 studies
- San Diego, CA5 studies
- Phoenix, AZ4 studies
- Santa Clarita, CA4 studies
- Huntington Beach, CA4 studies
- Pittsburgh, PA4 studies
- Washington, DC4 studies
- San Francisco, CA3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Overweight23 studies
- Multiple Myeloma21 studies
- Ulcerative Colitis21 studies
- Alzheimer's Disease20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.